Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 2/20 | 0.58 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.58 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | SRD5A2 | P31213 | 3/20 | 0.54 |
| ▸ | HTR6 | P50406 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | ATM | Q13315 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HTR3A | P46098 | 1/20 | 0.48 |
| ▸ | BACE1 | P56817 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9467870 | 0.98 | HTR2A (0.56) | HTR2ATAAR1SMN1; SMN2CYP2A6LOXL2 | |
| Benzophenone SCHEMBL4653152 | 0.91 | TAAR1 (0.64) | HTR2ATAAR1SMN1; SMN2CYP2A6LOXL2 | |
| Benzophenone SCHEMBL4622258 | 0.91 | TAAR1 (0.64) | HTR2ATAAR1SMN1; SMN2CYP2A6LOXL2 | |
| SCHEMBL7889494 | 0.87 | ALDH1A1 (0.67) | SMN1; SMN2ALDH1A1SRD5A2KMT2AMEN1 | |
| SCHEMBL7898126 | 0.85 | ALDH1A1 (0.64) | ALDH1A1SRD5A2KMT2AMEN1L3MBTL1 | |
| SCHEMBL203283 | 0.83 | ALDH1A1 (0.61) | TAAR1SMN1; SMN2LOXL2ALDH1A1SRD5A2 | |
| Sulfanilamide SCHEMBL27496763 | 0.83 | MEN1 (0.64) | HTR6KMT2AMEN1 | |
| SCHEMBL10905589 | 0.83 | ATM (0.59) | HTR2ATAAR1SMN1; SMN2CYP2A6LOXL2 | |
| SCHEMBL9148047 | 0.82 | MAOB (0.69) | ALDH1A1SRD5A2KMT2AMEN1HDAC1 | |
| SCHEMBL9039075 | 0.82 | TAAR1 (0.69) | TAAR1SMN1; SMN2CYP2A6ALDH1A1SRD5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119510643-A | Method for improving quality control of dopamine hydrochloride injection | 广州艾奇西医药科技有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-116731375-A | Polymer surface modification method, obtained surface modified polymer and application thereof | 中国科学院赣江创新研究院 | 2023-09-12 | — | — | CN | claimed |
| CN-119510643-B | Method for improving quality control of dopamine hydrochloride injection | 广州艾奇西医药科技有限公司 | 2025-07-25 | — | — | CN | disclosed |
| CN-119510643-A | Method for improving quality control of dopamine hydrochloride injection | 广州艾奇西医药科技有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-119510643-A | Method for improving quality control of dopamine hydrochloride injection | 广州艾奇西医药科技有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-116731375-A | Polymer surface modification method, obtained surface modified polymer and application thereof | 中国科学院赣江创新研究院 | 2023-09-12 | — | — | CN | disclosed |
| EP-3554571-A1 | HYDROPHOBIC ACTIVE AGENT PARTICLE COATINGS AND METHODS FOR TREATMENT | Surmodics, Inc. (US) | 2019-10-23 | — | — | EP | disclosed |
| WO-2018112196-A1 | HYDROPHOBIC ACTIVE AGENT PARTICLE COATINGS AND METHODS FOR TREATMENT | SURMODICS, INC. (US) | 2018-06-21 | — | — | WO | disclosed |
| US-9399633-B2 | Photoinitiators | COLOPLAST A/S (DK) | 2016-07-26 | — | — | US | disclosed |
| US-20160060243-A1 | NOVEL PHOTOINITIATORS | COLOPLAST A/S (DK) | 2016-03-03 | — | — | US | disclosed |
| US-9212160-B2 | Photoinitiators | COLOPLAST A/S (DK) | 2015-12-15 | — | — | US | disclosed |
| US-20070104757-A1 | LATENT REACTIVE BLOOD COMPATIBLE AGENTS | Surmodics Coatings, LLC | 2007-05-10 | — | — | US | disclosed |
| US-20070082022-A1 | LATENT REACTIVE BLOOD COMPATIBLE AGENTS | Surmodics Coatings, LLC | 2007-04-12 | — | — | US | disclosed |
| EP-0755949-B1 | Radiation curable masses containing covalently bonded photoinitiators | BASF AG (DE) | 2000-04-12 | — | — | EP | disclosed |
| US-5859084-A | Radiation-curable compositions containing photoinitiators linked by a covalent bond | BASF AKTIENGESELLSCHAFT (DE) | 1999-01-12 | — | — | US | disclosed |
| EP-0755949-A1 | Radiation curable masses containing covalently bonded photoinitiators | BASF AKTIENGESELLSCHAFT (DE) | 1997-01-29 | — | — | EP | disclosed |
| US-5232946-A | Promoting weight gain and reduction of blood sugar and fat deposits in animals, feed efficiency | DR. KARL THOMAE GMBH (DE) | 1993-08-03 | — | — | US | disclosed |
| EP-0400011-A1 | NEW PHENYLETHANOLAMINES. | BOEHRINGER INGELHEIM VETMED (DE) | 1990-12-05 | — | — | EP | disclosed |
| EP-0375791-A1 | Phenyl ethanol amines, their use as pharmaceutical compounds and as performance stimulants in animals, as well as processes for their preparation | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 1990-07-04 | — | — | EP | disclosed |
| WO-1990006299-A1 | NEW PHENYLETHANOLAMINES | BOEHRINGER INGELHEIM VETMEDICA GMBH (DE) | 1990-06-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160060243-A1 | NOVEL PHOTOINITIATORS | UROD, PUF60, PPOX | HTR2A 961/4885TAAR1 689/4885SMN1; SMN2 4690/4885 |
| US-20070082022-A1 | LATENT REACTIVE BLOOD COMPATIBLE AGENTS | FGB, HLA-A, HLA-C | HTR2A 2644/4885TAAR1 1262/4885SMN1; SMN2 4383/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.